首页> 外文期刊>Journal of addiction medicine >Methadone Management of Withdrawal Associated With Loperamide-related Opioid Use Disorder
【24h】

Methadone Management of Withdrawal Associated With Loperamide-related Opioid Use Disorder

机译:与洛柳胺相关的阿片类药物的戒断戒断

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Loperamide hydrochloride is an over-the-counter anti-diarrheal agent, acting via mu-opioid receptor agonist effects in the intestinal myenteric plexus. Although preclinical investigations suggested that abuse liability associated with loperamide use is low, there are increasing numbers of cases reported to the US Food and Drug Administration, of abuse, dependence, and withdrawal associated with loperamide use. A case of a patient with opioid use disorder, that is, in the form of protracted loperamide excess use, requiring management of withdrawal with methadone is presented. Management of withdrawal from abrupt loperamide discontinuation has not been discussed in the literature. Long-term treatment issues are also described.
机译:盐酸洛哌胺是一种过逆腹泻剂,通过肠道神经丛中的Mu-阿片受体激动剂作用作用。 虽然临床前调查表明,与洛哌米德使用相关的滥用责任低,但越来越多的案件向美国食品和药物管理报告,滥用,依赖性和与洛哌米德使用相关的戒断。 提出了一种患有阿片类药物障碍的患者的患者,即以持久的洛哌米德过量使用的形式提出,需要用美沙酮进行戒断。 在文献中尚未讨论从突然的洛哌米德停止撤退的戒断。 还描述了长期治疗问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号